I-15307-79-6 i-Diclofenac Sodium ene-USP BP yoMgangatho woMgangatho kunye ne-Ready Stock Anti-inflammatory Agent Featured Featured

I-15307-79-6 i-Diclofenac Sodium kunye ne-USP BP yoMgangatho woMgangatho kunye ne-Agent eLungeleyo ye-Anti-inflammatory.

Inkcazelo emfutshane:

ImiGangatho yoMgangatho:USP, BP, EP okanye njengoko kufuneka

Umthamo:10000Kg/ngenyanga

Beka ubomi kwishelufa:Iminyaka emithathu

Isicelo:isetyenziselwa ukukhulula intlungu edibeneyo kwi-arthritis;iklasi yamachiza eyaziwa ngokuba ngamachiza achasene nokudumba (nonsteroidal anti-inflammatory drugs) (NSAIDs)

Iqela eliluncedo:Iqela lentengiso yokuthumela ngaphandle abanamava kunye noqeqesho lobungcali kumzi-mveliso

Thumela i-imeyile kuthi Khuphela njengePDF

Iinkcukacha zeMveliso

FAQ

Iithegi zeMveliso

Imvelisoigama	Diclofenac sodium
Izithethantonye	2-[(2,6-Dichlorophenyl)amino]benzeneacetic acid isodiyam ityuwa
Inombolo yeCAS.	15307-79-6
Imbonakalo	I-crystalline powder emhlophe okanye etyheli kancinane, i-hygroscopic kancinane
Ifomula yeemolekyuli	C₁₄H₁₀Cl₂NNaO₂
Ubunzima beMolekyuli	318.13
Isicelo	Ibakala leyeza okanye injongo yophando
Ukupakisha	Ngokwesicelo sakho
Ugcino	Londoloza kwizikhongozeli eziqinile, ezikwaziyo ukumelana nokukhanya kwindawo epholileyo

I-Sodium yeDiclofenacInombolo yeCAS: 15307-79-6
IZINTO	IMIGANGATHO	IZIPHUMO
Imbonakalo	I-crystalline powder emhlophe okanye etyheli kancinane, i-hygroscopic kancinane	Umgubo omhlophe wekristale
Ukuchongwa	Okuhle	Iyahambelana
Imbonakaloyesisombululo	440≤0.05	Iyahambelana
Izinto ezinxulumeneyo	Ukungcola okukodwa ≤0.2%	0.14%
Izinto ezinxulumeneyo	Ubumdaka bubonke ≤0.5%	0.25%
Iintsimbi ezinzima	Iyahambelana	Iyahambelana
Ilahleko ekomisweni	≤0.5%	0.25%
Isivavanyi	99.09%-101.0%	99.58%
Ukuqukumbela: Ithobela umgangatho weBP2015.

Ulwazi lweNkampani

√ Amava apheleleyo omaleko wolawulo kumzi-mveliso kunye namagcisa anezakhono abalandeli;
√ Umgangatho usoloko uyingqwalasela yethu ephezulu, inkqubo yeQC eQinisekileyo;
√ Iminyaka eli-11 yamava eqela lokuthengisa kumazwe angaphandle;
√ ilebhu yeR&D eZimeleyo;
√ Iindibano zocweyo zeGMP ezimbini ezityikityiweyo zexesha elide;
√ Imithombo etyebileyo yeefektri ezininzi ezingasebenziyo ukulungiselela iprojekthi elungelelanisiweyo;
√ Iqela elisebenzayo eliSebenzayo ngokuSebenzayo ngendlela engaguqukiyo.
imgsaf